2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …

RA Byrne, X Rossello, JJ Coughlan… - … Heart Journal: Acute …, 2024 - academic.oup.com
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

[PDF][PDF] 2023 ESC Guidelines for the management of acute coronary syndromes.

RA Byrne, X Rossello, JJ Coughlan, E Barbato, C Berry… - 2024 - repisalud.isciii.es
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction

S Hokimoto, K Kaikita, S Yasuda, K Tsujita… - Circulation …, 2023 - jstage.jst.go.jp
In 2008, the Guidelines for diagnosis and treatment of patients with vasospastic angina
(coronary spastic angina) 1 were developed by the Japanese Circulation Society, and the …

Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement

TH Schindler, WF Fearon, M Pelletier-Galarneau… - Cardiovascular …, 2023 - jacc.org
Angina pectoris and dyspnea in patients with normal or nonobstructive coronary vessels
remains a diagnostic challenge. Invasive coronary angiography may identify up to 60% of …

Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review

BA Samuels, SM Shah, RJ Widmer, Y Kobayashi… - Journal of the American …, 2023 - jacc.org
Angina with nonobstructive coronary arteries (ANOCA) is increasingly recognized and may
affect nearly one-half of patients undergoing invasive coronary angiography for suspected …

Coronary angiography-derived index of microvascular resistance

H Ai, Y Feng, Y Gong, B Zheng, Q **… - Frontiers in …, 2020 - frontiersin.org
A coronary angiography-derived index of microvascular resistance (caIMR) is proposed for
physiological assessment of microvasular diseases in coronary circulation. The aim of the …

[HTML][HTML] Definition and epidemiology of coronary microvascular disease

C Bradley, C Berry - Journal of Nuclear Cardiology, 2022 - Elsevier
Ischemic heart disease remains one of the leading causes of death and disability worldwide.
However, most patients referred for a noninvasive computed tomography coronary …

Management of ischaemia with non-obstructive coronary arteries (INOCA)

JF Beltrame, R Tavella, D Jones, C Zeitz - Bmj, 2021 - bmj.com
Up to half of patients undergoing elective coronary angiography for the investigation of chest
pain do not present with evidence of obstructive coronary artery disease. These patients are …